NRS 630.146
Website: Additional requirements concerning posting of information relating to pharmaceutical manufacturers.

The Board shall post on a website or other Internet site that is operated or administered by or on behalf of the Board:

1.

A general description of the basic elements of the Compliance Program Guidance for Pharmaceutical Manufacturers that is published by the Office of Inspector General of the United States Department of Health and Human Services, or links to websites or other Internet sites that are operated or administered by or on behalf of the Office of Inspector General where such information may be obtained;

2.

A general description of the process for reporting unlawful or unethical conduct by pharmaceutical manufacturers to the Office of Inspector General, or links to websites or other Internet sites that are operated or administered by or on behalf of the Office of Inspector General where such information may be obtained; and

3.

A current telephone number for the Office of Inspector General.
LICENSES
General Provisions

Source: Section 630.146 — Website: Additional requirements concerning posting of information relating to pharmaceutical manufacturers., https://www.­leg.­state.­nv.­us/NRS/NRS-630.­html#NRS630Sec146.

Last Updated

Feb. 5, 2021

§ 630.146’s source at nv​.us